The Spectrum of Neurologic Disease Associated with Anti-GM1 Antibodies
Neurol 40:1067-1072, Sadiq,S.A.,et al, 1990
Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016
The Acquired Metabolic Disorders of the Nervous System, Ischemic-Hypoxic Encephalopathy
Adams & Victors Principles of Neurology Chp 40, pg 1133, Ropper, A.H.,et al, 2014
Amyotrophic lateral Sclerosis Mimic Syndromes, A Population-Based Study
Arch Neurol 57:109-113, Traynor,B.J.,et al, 2000
Motor Neuron Syndromes in Cancer Patients
Ann Neurol 41:722-730, 7031997., Forsyth,P.A.,et al, 1997
Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996
Diagnosing Motor Neurone Disease
BMJ 312:650-651, Chancellor,A.M., 1996
Immunoassays Fail to Detect Antibodies Against Neuronal Calcium Channels in Amyotrophic Lateral Sclerosis Serum
Ann Neurol 40:695-700, 6911996., Arsac,C.,et al, 1996
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Amyotrophic Lateral Sclerosis Patient Antibodies Label CA2+Channel a1 Subunit
Ann Neurol 35:164-171, 1311994., Fumiharu,K.,et al, 1994
Growth Factors:Potential Therapeutic Applications in Neurology
JNNP 54:1445-1450, Drago,J.,et al, 1994
Cell Culture Evidence for Neuronal Degeneration in ALS to Glutamate AMPA/Kainate Receptors
Lancet 341:265-268, Couratier,P.,et al, 1993
Motor Neuron Diseases and Amyotrophic Lateral Sclerosis:GM1 Antibodies and Paraproteinemia
Neurol 43:418-420, Sanders,K.A.,et al, 1993
Polyglucosan Body Disease Simulating Amyotrophic Lateral Sclerosis
Neurol 43:785-790, McDonald,T.D.,et al, 1993
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
NEJM 326:1464-1468, 14931992., Rothstein,J.D.,et al, 1992
Amyotrophic Lateral Sclerosis and Lymphoma:Bone Marroe Examination and Other Diagnostic Tests
Neurol 42:1101-1102, Rowland,L.P.,et al, 1992
Serum Antibodies to L-Type Calcium Channels in Patients with Amyotrophic Lateral Sclerosis
NEJM 327:1721-1728, 17521992., Smith,R.G.,et al, 1992
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Polyclonal IgM Anti-GM1 Ganglioside Antibody in Patients with Motor Neuron Disease and Variants
Ann Neurol 27:558-563, Salazar-Grueso,E.F.,et al, 1990
Serum Antibodies to GM1 Ganglioside in Amytrophic Lateral Sclerosis
Neurol 38:1457-1461, Pestronk,A.,et al, 1988
Neurological Clues from Environmental Neurotoxins
BMJ 295:346-347, Martyn,C.N., 1987
Amyotrophic Lateral Sclerosis, Associated Clinical Disorders & Immunological Evaluations
Arch Neurol 43:234-238, Appel,S.H.,et al, 1986
Motor Neuron Disease & Plasma Cell Dyscrasia
Neurol 36:1429-1436, Shy,M.E.,et al, 1986
Oligoclonal IgG Bands in Cerebrospinal Fluid in Various Neurological Diseases
Ann Neurol 13:434-439, Chu,A.B.,et al, 1983
Double-Blind Study of Modified Neurotoxin in Motor Neuron Disease
Neurol 29:77-81, Tyler,H.R., 1979
Mononeuropathy of the Deep Palmar Branch of the Ulnar Nerve in a Diabetic
Arch Neurol 32:564, Finelli,P.F., 1975
Epidemiology of Motor-Neuron Diseases
NEJM 288:1047, Bobwick,A.R.,et al, 1973
The Geography of Neurology
BMJ 2:506, Spillane,J.D., 1972
Lower Motor & Primary Sensory Neuron Diseases with Peroneal Muscular Atrophy (II)
Arch Neurol 18:619, Dyck,P.,et al, 1968
Clinical Cases-Dx:Functional Approach to Neuroanatomy pp 477-490 Earl Lawrence House
McGraw Hill 1967., , 1967
Diseases of Muscles-Clinical Manifestations & Differential Diagnosis
The New Physic 263, 1967, Oct., Boshes,L., 1967